HOME >> BIOLOGY >> NEWS
Other highlights in the Jan. 16 issue of JNCI

DNA Repair Capability May Influence Likelihood of Developing Melanoma
A new study suggests that the bodys ability to repair DNA damage caused by ultraviolet radiation from sunlight may influence the risk of melanoma in people who do not tan easily and who have many unusually large and irregularly shaped moles (called dysplastic nevi).

Dysplastic nevi and low tanning ability are known risk factors for melanoma. Exposure to UV radiation from sunlight is also associated with an increased risk of the disease. Maria Teresa Landi, M.D., Ph.D., of the National Cancer Institute, and colleagues looked at a group of patients in Italy to determine whether the cellular capacity to repair DNA damage is associated with the risk of cutaneous malignant melanoma.

By studying 132 patients with melanoma and 145 control subjects, the authors found that, independent of other risk factors, DNA repair capacity was not associated with an increased risk of melanoma. However, among patients who had low tanning ability or dysplastic nevi, those with a low DNA repair capacity had a higher risk of the disease than those with a high DNA repair capacity. These results are presented in the Jan. 16 issue of the Journal of the National Cancer Institute.

Contact: NCI Press Office, (301) 496-6641

Predictive Value of HPV Testing in Managing Equivocal Pap Tests Improves with Age, Study Shows
Each year, about 50 million Pap tests are taken in the United States, 2 million of which are not entirely normal. Most Pap tests that are not clearly normal show equivocal (aytpical squamous cells of undetermined significance [ASCUS]) or mild (low-grade squamous intraepithelial lesions [LSIL]) abnormalities.

Only about 5% of women with ASCUS and 10% of those with LSIL have a known precursor to cancer, called cervical intraepithelial neoplasia 3 (CIN3). Therefore, referring all women with ASCUS or LSIL for colposcopy (examination of the cervix
'"/>

Contact: Linda Wang
jncinews@oup-usa.org
301-594-2927
Journal of the National Cancer Institute
15-Jan-2002


Page: 1 2 3 4

Related biology news :

1. Other highlights in the September 1 JNCI
2. Other highlights in the August 18 JNCI
3. Other highlights in the August 4 JNCI
4. Other highlights in the July 7 JNCI
5. Other highlights in the June 16 JNCI
6. Other Highlights in the June 2 JNCI
7. Other highlights in the May 19 JNCI
8. Other highlights in the May 5 JNCI
9. Other highlights of the March 17 issue of JNCI
10. Other highlights in the March 3 issue of JNCI
11. Other highlights in the February 18 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
Breaking Biology Technology:
Cached News: